Get the Stockscreener App
45.32
2.26%
1.00
After Hours:
44.40
-0.92
-2.03%
Omnicell Inc stock is traded at $45.32, with a volume of 204.82K.
It is up +2.26% in the last 24 hours and down -3.37% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
See More
Previous Close:
$44.32
Open:
$44.44
24h Volume:
204.82K
Relative Volume:
0.39
Market Cap:
$2.10B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-98.52
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
+2.86%
1M Performance:
-3.37%
6M Performance:
+69.36%
1Y Performance:
+33.96%
1-Day Range:
$44.09
$45.38
1-Week Range:
$42.80
$45.38
52-Week Range:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
45.32 | 2.10B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
213.03 | 34.59B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
67.12 | 11.60B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.22 | 10.31B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.47 | 8.45B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
The past three years for Omnicell (NASDAQ:OMCL) investors has not been profitable - Simply Wall St
Pharmacy Automation Market Size, Growth Status to 2033 TOSHO, Takazono, ScriptPro, BD, Baxter, Omnicell - openPR
Principal Financial Group Inc. Cuts Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Analysts Set Omnicell, Inc. (NASDAQ:OMCL) Target Price at $52.00 - MarketBeat
Omnicell (NASDAQ:OMCL) Trading Down 2.4%What's Next? - MarketBeat
Omnicell (NASDAQ:OMCL) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Jane Street Group LLC Has $2.20 Million Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
4 Healthcare Technology Innovators to Invest in Before the New Year - Zacks Investment Research
Why Omnicell (OMCL) Might be Well Poised for a Surge - MSN
Medication Management Market (2024-2032): Industry Insights, - openPR
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Nigeria
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - Investing.com
Don't Ignore The Insider Selling In Omnicell - Simply Wall St
Wellington Management Group LLP Sells 1,148,356 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell director Mark Parrish sells shares worth $567,638 By Investing.com - Investing.com Australia
Omnicell, Inc. (NASDAQ:OMCL) Short Interest Update - MarketBeat
Omnicell partners with Gollmann to expand pharmacy automation solutions - Pharmacy Business
Omnicell director Mark Parrish sells shares worth $567,638 - Investing.com India
Centiva Capital LP Sells 19,341 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 643,292 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Director Mark Parrish Sells 12,000 Shares of Omnicell Inc (OMCL) - GuruFocus.com
What Makes Omnicell (OMCL) a New Strong Buy Stock - MSN
Omnicell Introduces OmniSphere Platform, Stock to Gain - MSN
Future-Proofing Growth of Medication Management - openPR
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS - The Eastern Progress Online
Central Fill Pharmacy Automation Market Emerging Trends and Growth Prospects 2032 |Omnicell, McKesson, Swisslog - openPR
Pharmacy Dispensing Automation Market Likely to Boost Future Growth by 2031: McKesson, Omnicell, Cerner - openPR
Omnicell (NASDAQ:OMCL) Lowered to "Hold" Rating by StockNews.com - MarketBeat
Omnicell Announces OmniSphere - Business Wire
Central Fill Pharmacy Automation Market Projected To Witness Substantial Growth, 2024-2031: ARxIUM Inc., - EIN News
Pier Capital LLC Buys New Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Healthcare Robotics Market to See Huge Growth by 2030: Stryker Corporation, Omnicell, ARxIUM - openPR
SageView Advisory Group LLC Acquires Shares of 11,019 Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
How To Trade (OMCL) - Stock Traders Daily
Charles Schwab Investment Management Inc. Grows Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health - Barchart
Omnicell Inc (OMCL) Trading Down 3.62% on Dec 3 - GuruFocus.com
Martingale Asset Management L P Invests $507,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bridgewater Associates LP - MarketBeat
Rockefeller Capital Management L.P. Acquires 16,116 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Bellevue Group AG Reduces Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report? - MSN
Omnicell (NASDAQ:OMCL) Stock Price Down 3.7%Time to Sell? - MarketBeat
Dynamic Technology Lab Private Ltd Sells 15,351 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
OMCL (Omnicell) PE Ratio without NRI : 32.58 (As of Nov. 30, 2024) - GuruFocus.com
Algert Global LLC Trims Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Intech Investment Management LLC Makes New Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):